TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07499674: Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Sponsor: Vergent Bioscience, Inc. · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 132 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$787,248

Rescue Site Savings

+$524,832

Unlock Full NCT07499674 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07499674 Rescue Dossier →